Literature DB >> 10208423

Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene.

W R Zeng1, P Watson, J Lin, S Jothy, R Lidereau, M Park, A Nepveu.   

Abstract

In breast cancer, loss of heterozygosity (LOH) has been described on the long arm of chromosome 7, at band q31, suggesting the presence of a tumor suppressor gene in this region. In this study, we have identified a second region of LOH on 7q, at band 7q22. Deletion of genetic material at 7q22 was found in all tumor types and grades and was associated with increased tumor size. The region of LOH at 7q22 in every case included one or more of three polymorphic markers that are located within the CUTL1 gene. LOH of 7q22 has also been documented in the case of human uterine leiomyomas (Zeng et al., 1997; Ishwad et al., 1997). Interestingly, in both leiomyomas and mammary tumors induced in transgenic mice expressing the Polyomavirus (PyV) large T (LT) antigen, immunocomplexes of CUTL1 and PyV LT antigen were detected (Webster et al., 1998). Altogether, genetic data in human breast cancer and biochemical analyses in breast tumors from transgenic mice suggest that CUTL1 is a candidate tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208423     DOI: 10.1038/sj.onc.1202519

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

2.  CASP, the alternatively spliced product of the gene encoding the CCAAT-displacement protein transcription factor, is a Golgi membrane protein related to giantin.

Authors:  Alison K Gillingham; Andrea C Pfeifer; Sean Munro
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

3.  The homeodomain protein CDP regulates mammary-specific gene transcription and tumorigenesis.

Authors:  Quan Zhu; Urmila Maitra; Dennis Johnston; Mary Lozano; Jaquelin P Dudley
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

4.  Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study.

Authors:  Keerthi K Nair; Gujjar Vittobarao Pramod; Kanad Chaudhuri; Lingappa Ashok
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 5.  CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.

Authors:  Zubaidah M Ramdzan; Alain Nepveu
Journal:  Nat Rev Cancer       Date:  2014-09-05       Impact factor: 60.716

Review 6.  Pre-clinical applications of transgenic mouse mammary cancer models.

Authors:  C J Kavanaugh; K V Desai; A Calvo; P H Brown; C Couldrey; R Lubet; J E Green
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

7.  Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas.

Authors:  Cristina Robledo; Juan L García; Rocío Benito; Teresa Flores; Manuela Mollejo; José Ángel Martínez-Climent; Eva García; Norma C Gutiérrez; Miguel A Piris; Jesús M Hernández
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

8.  RAS transformation requires CUX1-dependent repair of oxidative DNA damage.

Authors:  Zubaidah M Ramdzan; Charles Vadnais; Ranjana Pal; Guillaume Vandal; Chantal Cadieux; Lam Leduy; Sayeh Davoudi; Laura Hulea; Lu Yao; Anthony N Karnezis; Marilène Paquet; David Dankort; Alain Nepveu
Journal:  PLoS Biol       Date:  2014-03-11       Impact factor: 8.029

9.  Germline large genomic alterations on 7q in patients with multiple primary cancers.

Authors:  R A R Villacis; T R Basso; L M Canto; A F Nóbrega; M I Achatz; S R Rogatto
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

10.  Micromanaging a large tumor suppressor.

Authors:  Yanmei Li; David E Spaner
Journal:  Cell Cycle       Date:  2012-12-06       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.